GLOBAL LYME ALLIANCE INC

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1999

Legal Domicile

Principal Officer

LAURA MACNEILL

Phone

2039691333

Tax Period

2023-01-01 to 2023-12-31

GLOBAL LYME ALLIANCE INC, founded in 1999, is a community nonprofit in the Health Care sector that reported $3.2M in total revenue in fiscal year 2023. Revenue grew 13% year-over-year, indicating healthy expansion.

Mission

GLOBAL LYME ALLIANCE IS THE LEADING NONPROFIT DEDICATED TO CONQUERING LYME AND OTHER TICK-BORNE DISEASES. OUR MISSION: CURE LYME AND OTHER TICK-BORNE DISEASES THROUGH INNOVATIVE RESEARCH, AWARENESS, AND EMPOWERING THE PATIENT VOICE.

Program Service Accomplishments

Program 1

Expenses: $1,454,657 Revenue: $100,000

GLOBAL LYME ALLIANCE (GLA) HAS A STRONG TRACK RECORD OF PROGRAM SERVICE ACCOMPLISHMENTS IN THREE MAJOR AREAS, MEASURED BY EXPENSES: RESEARCH ADVANCEMENTS: GLA INVESTS IN RESEARCH, DRIVING SIGNIFICANT PROGRESS IN LYME AND TICK-BORNE DISEASE STUDIES. THEIR CONTRIBUTIONS INCLUDE GROUNDBREAKING WORK IN DIAGNOSTICS, TREATMENT, AND UNDERSTANDING OF LYME BACTERIA. NOTABLE ACHIEVEMENTS COMPRISE CHARACTERIZING CHRONIC LYME DISEASE, GENOME SEQUENCING OF BORRELIA BURGDORFERI STRAINS, UNCOVERING ANTIBIOTIC RESISTANCE MECHANISMS, AND DOCUMENTING IMMUNE DYSFUNCTION IN PATIENTS. RECENT DISCOVERIES INCLUDE THE ROLE OF CELL WALL-DEFICIENT FORMS (L-FORMS) IN CHRONIC INFECTIONS, POTENTIALLY AIDING EARLY LYME DISEASE CURE.PATIENT SUPPORT: GLA IS COMMITTED TO AIDING PATIENTS, CAREGIVERS, AND LOVED ONES AFFECTED BY THESE DISEASES. THEY OFFER VARIOUS SUPPORT PROGRAMS, SUCH AS ACCESS TO SPECIALISTS, FINANCIAL ASSISTANCE INFORMATION, CLINICAL TRIAL OPPORTUNITIES, EMOTIONAL SUPPORT MENTORSHIP, AND EDUCATIONAL MATERIALS. THEIR HOLISTIC APPROACH ADDRESSES PATIENTS AND FAMILIES' CHALLENGES COMPREHENSIVELY.KNOWLEDGE AND AWARENESS: GLA'S RESEARCH AND EDUCATIONAL INITIATIVES HAVE PLAYED A PIVOTAL ROLE IN ENHANCING UNDERSTANDING AND AWARENESS OF LYME AND TICK-BORNE DISEASES. THEIR FUNDING OF STUDIES CONNECTING LYME DISEASE TO PSYCHIATRIC DISORDERS HAS BROADENED AWARENESS OF THE DISEASES' IMPACT ON PATIENTS' WELL-BEING. MOREOVER, GLA'S DEDICATION TO SHARING EDUCATIONAL RESOURCES AND CLINICAL TRIAL INFORMATION EMPOWERS THE COMMUNITY TO MAKE INFORMED HEALTH DECISIONS.

Program 2

Expenses: $960,114 Revenue: $0

GLOBAL LYME ALLIANCE CONTINUES TO ADVANCE THE RESEARCH AND SCIENCE FOR LYME AND OTHER TICK-BORNE DISEASES THROUGH ITS ROBUST RESEARCH GRANT PROGRAM. GLA'S SCIENTIFIC ADVISORY BOARD (SAB), COMPRISED OF DISTINGUISHED RESEARCHERS IN MULTIDISCIPLINARY FIELDS IN LYME AND TICK-BORNE DISEASE, PROVIDES STRATEGIC GUIDANCE TO GLOBAL LYME ALLIANCE IN ITS REVIEW AND AWARD PROCESS TO ADVANCE RESEARCH AT LEADING INSTITUTIONS WITH A GOAL OF IMPROVING DIAGNOSTICS AND TREATMENT OF LYME AND OTHER TICK-BORNE ILLNESSES.AS THE LEADING PATIENT VOICE LYME NON-PROFIT MEASURED BY OUR AUDIENCE SHARE, GLA GETS INPUT FROM OUR MEDICAL ADVISORY BOARD AND PATIENT ADVOCATES TO DRIVE RESEARCH DISCOVERY; GLA BRIDGES THE GAP BETWEEN PATIENT AND RESEARCH TO INFORM WHERE SCIENCE NEEDS TO GO TO FIND A CURE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $3,325,594

Program Service Revenue $100,000

Investment Income $93,841

Other Revenue $-298,420

TOTAL REVENUE $3,221,015

Expense Breakdown

Grants Paid $960,114

Salaries & Benefits $1,138,978

Fundraising Expenses $499,148

Program Expenses $2,414,771

Other Expenses $1,065,887

TOTAL EXPENSES $3,164,979

Year-over-Year Comparison

	2023	2022	Change
Revenue	$3,221,015	$2,854,709	+0.1%
Expenses	$3,164,979	$2,721,867	+0.2%
Net Income	$56,036	$132,842	-0.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

532

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$237,596

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PAUL ROSS	CHAIRMAN	10.00	Officer Director	$0	$0	$0
DEBORAH SICILIANO	VICE CHAIR	2.00	Officer Director	$0	$0	$0
DIANE BLANCHARD	VICE CHAIR	4.00	Officer Director	$0	$0	$0
CHARLES BALDUCCI	VICE CHAIR	2.00	Officer Director	$0	$0	$0
JANET VACCARO	SECRETARY	4.00	Officer Director	$0	$0	$0
HENRY DOSCH	TREASURER	4.00	Officer Director	$0	$0	$0
ROBERT KOBRE	DIRECTOR	4.00	Director	$0	$0	$0
NANCY DEL GENIO	DIRECTOR	10.00	Director	$0	$0	$0
DAVID NOLAN	DIRECTOR	2.00	Director	$0	$0	$0
EDWARD O'CONNELL	DIRECTOR	2.00	Director	$0	$0	$0
KAREN PEETZ	DIRECTOR	2.00	Director	$0	$0	$0
DANA MCAVITY	DIRECTOR (UNTIL 9/1/2023)	2.00	Director	$0	$0	$0
BRETT KRISTOFF	DIRECTOR	2.00	Director	$0	$0	$0
LORRIE NADEL	DIRECTOR	2.00	Director	$0	$0	$0
RIDGWAY BARKER	DIRECTOR	2.00	Director	$0	$0	$0
CHRIS CORRINET	DIRECTOR	2.00	Director	$0	$0	$0
DAVID GERSTNER	DIRECTOR	2.00	Director	$0	$0	$0
JULIA KNOX-COMEAU	DIRECTOR	2.00	Director	$0	$0	$0
STEVE LEFKOWITZ	DIRECTOR	2.00	Director	$0	$0	$0
LEWIS LEONE	DIRECTOR	2.00	Director	$0	$0	$0
STEVEN MARTIN	DIRECTOR	2.00	Director	$0	$0	$0
NORMA RUSSO	DIRECTOR	2.00	Director	$0	$0	$0
ALEXANDER TISCH	DIRECTOR	2.00	Director	$0	$0	$0
ERIN WALKER	DIRECTOR	2.00	Director	$0	$0	$0
AZIZ SYRIANI	DIRECTOR	2.00	Director	$0	$0	$0
BRENT PATRY	DIRECTOR	2.00	Director	$0	$0	$0
KAREN KELLY	DIRECTOR	2.00	Director	$0	$0	$0
MACKENZIE VATH	DIRECTOR	2.00	Director	$0	$0	$0
ROSE ANASTASIO	DIRECTOR	2.00	Director	$0	$0	$0
LAURA MACNEILL	CHIEF EXECUTIVE OFFICER	40.00	Officer	$237,596	$0	$237,596
TIMOTHY SELLATI	CHIEF SCIENTIFIC OFFICER	40.00	Highest	$233,888	$35,278	$269,166
STEVEN PECOCK	DIRECTOR OF DEVELOPMENT	40.00	Highest	$137,500	$0	$137,500
LINDSY SWIFT	DIRECTOR OF MKTG & COMM	40.00	Highest	$106,720	$0	$106,720

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$3,221,015	$3,164,979	$3,957,959	$56,036
2022	$2,854,709	$2,721,867	$3,843,093	$132,842
2021	$2,629,195	$3,557,214	$4,008,676	$-928,019
2021	$2,629,195	$3,557,214	$4,008,676	$-928,019
2020	$2,874,719	$4,045,643	$4,655,690	$-1,170,924
2019	$4,898,928	$4,309,851	$5,677,001	$589,077
2018	$4,623,616	$4,312,946	$4,948,954	$310,670